It is defined as a BC subtype absence of estrogen receptor (ER) and progesterone receptor (PR) and lack of HER2 amplification/overexpression [2, 4, 5], thus is unlikely driven by hormornal or HER2 signaling [6]. The gene discussed is ERBB2; the disease is breast cancer.